SOUTH SAN FRANCISCO, Calif. and WATERTOWN, Mass., May 21, 2026 — Calico Life Sciences LLC (Calico), a clinical-stage biotechnology organization focused on aging and age-related diseases and founded by Alphabet Inc. and Arthur D. Levinson, Ph.D., and Nexo Therapeutics Inc. (Nexo), today announced a multi-target collaboration to discover and develop small molecule therapeutics for challenging […]
Category: Press Releases
Nexo Therapeutics Launches With $60 Million Series A Financing
Nexo Therapeutics launched with $60 million in Series A funding led by Versant Ventures and outlined a platform designed to discover covalent drugs against previously intractable cancer targets. […]
Read More… from Nexo Therapeutics Launches With $60 Million Series A Financing
MD Anderson and Nexo Therapeutics announce strategic research collaboration to advance new therapies against intractable targets
MD Anderson and Nexo Therapeutics announced a multi-year collaboration that combines Nexo’s discovery platform with MD Anderson’s TRACTION capabilities to move new small-molecule cancer therapies toward the clinic. […]